2,418
Views
5
CrossRef citations to date
0
Altmetric
Immunotherapeutics – Research Article

Advancing humanized monoclonal antibody for counteracting fentanyl toxicity towards clinical development

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Article: 2122507 | Received 27 Jun 2022, Accepted 04 Sep 2022, Published online: 04 Oct 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Suky Martinez, Hannah Harris, Thomas Chao, Rachel Luba, Marco Pravetoni, Sandra D Comer & Jermaine D Jones. (2023) The potential role of opioid vaccines and monoclonal antibodies in the opioid overdose crisis. Expert Opinion on Investigational Drugs 32:3, pages 181-185.
Read now

Articles from other publishers (4)

Mingliang Lin, Lisa M. Eubanks, Nishant M. Karadkhelkar, Steven Blake & Kim D. Janda. (2023) Catalytic Antibody Blunts Carfentanil-Induced Respiratory Depression. ACS Pharmacology & Translational Science 6:5, pages 802-811.
Crossref
Karam Chamoun, Lucie Chevillard, Aline Hajj, Jacques Callebert & Bruno Mégarbane. (2023) Mechanisms of Neurorespiratory Toxicity Induced by Fentanyl Analogs—Lessons from Animal Studies. Pharmaceuticals 16:3, pages 382.
Crossref
Gianna Triller, Evi P. Vlachou, Hamidreza Hashemi, Monique van Straaten, Johan P. Zeelen, Yosip Kelemen, Carly Baehr, Cheryl L. Marker, Sandra Ruf, Anna Svirina, Monica Chandra, Katharina Urban, Anastasia Gkeka, Sebastian Kruse, Andreas Baumann, Aubry K. Miller, Marc Bartel, Marco Pravetoni, C. Erec Stebbins, F. Nina Papavasiliou & Joseph P. Verdi. (2023) A trypanosome-derived immunotherapeutics platform elicits potent high-affinity antibodies, negating the effects of the synthetic opioid fentanyl. Cell Reports 42:2, pages 112049.
Crossref
Justas V. Rodarte, Carly Baehr, Dustin Hicks, Tyler L. Liban, Connor Weidle, Peter B. Rupert, Rajwana Jahan, Abigail Wall, Andrew T. McGuire, Roland K. Strong, Scott Runyon, Marco Pravetoni & Marie Pancera. (2023) Structures of drug-specific monoclonal antibodies bound to opioids and nicotine reveal a common mode of binding. Structure 31:1, pages 20-32.e5.
Crossref